Noncompliance in organ transplant recipients: a literature review.

The consequences of failing to comply to doctor's instructions can be damaging and devastating for the individual patient and their family. Noncompliance also leads to waste, as it reduces the potential benefits of therapy, and to the extra cost of treating avoidable consequent morbidity. Life-long immunosuppression is a prerequisite for good graft function, and noncompliance is often associated with late acute rejection episodes, graft loss, and death. It might be assumed that transplant patients constitute a highly motivated group, and that compliance would be high. Unfortunately, this is not the case: overall noncompliance rates vary from 20 to 50%. This overview includes literature on heart, liver, and kidney transplants in adult and pediatric transplant patients. Compliance behavior after transplantation, noncompliance and its relationship to organ loss and death, retransplantation outcome after graft loss due to noncompliance, and reasons for postoperative noncompliance will be addressed.

[1]  D. Sherman,et al.  Psychiatric outcome in alcoholic liver transplant patients. , 1994, QJM : monthly journal of the Association of Physicians.

[2]  J. Cramer.  Practical issues in medication compliance. , 1999, Transplantation proceedings.

[3]  R. Gaston,et al.  Late renal allograft loss: noncompliance masquerading as chronic rejection. , 1999, Transplantation proceedings.

[4]  K. Lawrence,et al.  Pediatric heart transplantation: the recipient’s perspective , 1992 .

[5]  C. Young,et al.  Living with a heart transplant: long‐term adjustment , 1992, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  R. Pollak,et al.  A STUDY OF TREATMENT COMPLIANCE FOLLOWING KIDNEY TRANSPLANTATION , 1993, Transplantation.

[7]  G. Ortalli.  Suicide by interruption of immunosuppressive therapy. , 1992, Journal of cardiothoracic and vascular anesthesia.

[8]  H. Nägele,et al.  Smoking after heart transplantation: an underestimated hazard? , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  J. Horder,et al.  The consultation and health outcomes. , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.

[10]  T. Beresford,et al.  Alcohol use after liver transplantation in alcoholics: A clinical cohort follow‐up study , 1997, Hepatology.

[11]  P. Frazier,et al.  Correlates of noncompliance among renal transplant recipients. , 1994, Clinical transplantation.

[12]  M. Robbins.  Medication adherence and the transplant recipient: helping patients at each stage of change. , 1999, Transplantation proceedings.

[13]  E. Keeffe,et al.  Liver transplantation for patients with alcoholism and end-stage liver disease. , 1993, The American journal of gastroenterology.

[14]  G. Klintmalm,et al.  Alcohol use following liver transplantation for alcoholic cirrhosis. , 1996, Transplantation.

[15]  S. Bartuś,et al.  Noncompliance in organ transplant recipients. , 1990, Transplantation.

[16]  J. Goodnight,et al.  Discontinuance of Immunosuppression in Renal Transplant Patients , 1975 .

[17]  K. Boudjema,et al.  Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls , 1994, The Lancet.

[18]  P A Shapiro,et al.  Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. , 1995, Transplantation.

[19]  G. Koren,et al.  Compliance with cyclosporine in adolescent renal transplant recipients , 1997, Pediatric Nephrology.

[20]  A. Hoitsma,et al.  MEDICATION COMPLIANCE AFTER RENAL TRANSPLANTATION , 1995, Transplantation.

[21]  F. Dobbels,et al.  Clinical risk associated with appointment noncompliance in heart transplant recipients. , 2000, Progress in transplantation.

[22]  B. Griffith,et al.  Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  P. Ruygrok,et al.  Survival after heart transplantation without regular immunosuppression. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  M. Gatley,et al.  To be taken as directed. , 1968, The Journal of the Royal College of General Practitioners.

[25]  A V Prochazka,et al.  The assessment of refill compliance using pharmacy records: methods, validity, and applications. , 1997, Journal of clinical epidemiology.

[26]  P. Shapiro,et al.  Compliance complications in cardiac patients. , 1997, The American journal of psychiatry.

[27]  L. Kory.  Nonadherence to immunosuppressive medications: a pilot survey of members of the transplant recipients international organization. , 1999, Transplantation proceedings.

[28]  T. Pullar,et al.  Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily , 1988, Clinical pharmacology and therapeutics.

[29]  P. Moons,et al.  Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  S. Greenstein,et al.  Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. , 1997, Advances in renal replacement therapy.

[31]  N. Zuhdi,et al.  Study of the relative incidences of psychosocial factors before and after heart transplantation and the influence of posttransplantation psychosocial factors on heart transplantation outcome. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  C. Blixen,et al.  Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. , 1996 .

[33]  P. Pouletty,et al.  Liquid medication dispensing and dose monitoring: the CycloTech Cyclosporine Oral Solution Dispenser. , 1999, Transplantation proceedings.

[34]  N. Sumrani,et al.  Causes of late renal allograft failure in the ciclosporin era. , 1992, Nephron.

[35]  M. Thompson,et al.  Medical compliance and its predictors in the first year after heart transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  J. Ehrich,et al.  Non-compliance following renal transplantation in children and adolescents , 1998, Pediatric Nephrology.

[37]  C. V. van Buren,et al.  Causes of graft loss beyond two years in the cyclosporine era. , 1990, Transplantation.

[38]  A. Novick,et al.  Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. , 1996, Transplantation.

[39]  W. Bechstein,et al.  Is orthotopic liver transplantation for end-stage alcoholic cirrhosis justified? , 1995, Transplantation proceedings.

[40]  W. Waters,et al.  The benefits of prescription information leaflets (1). , 1989, British journal of clinical pharmacology.

[41]  K. Grady,et al.  Predictors of compliance with diet 6 months after heart transplantation. , 1995, Heart & lung : the journal of critical care.

[42]  A. Matas,et al.  Retransplantation after renal allograft loss due to noncompliance. Indications, outcome, and ethical concerns. , 1995, Transplantation.

[43]  H. D. Hoskins,et al.  The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. , 1991, Journal of ocular pharmacology.

[44]  P. Kimmel,et al.  Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantation. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  J. Neuberger,et al.  Liver transplantation for alcoholic liver disease: Evaluation of a selection protocol , 1997, Hepatology.

[46]  D. Hull,et al.  Noncompliance in Organ Transplant Recipients , 1989, Transplantation.

[47]  S. Kaplan,et al.  Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease , 1989, Medical care.

[48]  E. Santiago-delpin,et al.  Psychosocial profile of noncompliant transplant patients. , 1991, Transplantation proceedings.

[49]  K. A. McKibbon,et al.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications , 1996, The Lancet.

[50]  N. Zuhdi,et al.  Medication noncompliance and its relationship to financial factors after heart transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[51]  J. Neumann,et al.  Patient noncompliance as a major cause of kidney graft failure. , 1997, Transplantation proceedings.

[52]  R. Didlake,et al.  Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. , 1988, Transplantation proceedings.

[53]  R. Zuwallack,et al.  Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. , 1998, American journal of respiratory and critical care medicine.

[54]  D. V. van Thiel,et al.  Orthotopic liver transplantation for alcoholic cirrhosis. , 1988, JAMA.

[55]  S. Geest,et al.  INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS , 1995, Transplantation.

[56]  A. Stergachis,et al.  Patient compliance in transplantation: a report on the perceptions of transplant clinicians. , 1999, Transplantation proceedings.

[57]  D. Raynor.  Patient compliance: the pharmacist's role , 1992 .

[58]  K. Meeter,et al.  Compliance with the medical regimen and partner's quality of life after heart transplantation , 1993, Quality of Life Research.

[59]  A R Feinstein,et al.  On white-coat effects and the electronic monitoring of compliance. , 1990, Archives of internal medicine.

[60]  P. Perney,et al.  Results and cost of orthotopic liver transplantation for alcoholic cirrhosis. , 1993, Transplantation proceedings.

[61]  G. Zibari,et al.  Liver transplantation for alcoholic liver disease. , 1993, Clinical transplantation.

[62]  W. Kruse,et al.  Dosage frequency and drug-compliance behaviour — a comparative study on compliance with a medication to be taken twice or four times daily , 2004, European Journal of Clinical Pharmacology.